LYMPHOGENiX Limited
PrivateLast Round
Pre Seed
Jul 8, 2025
Total Funding Raised
$340,000
Company Overview
LYMPHOGENiX Limited is a biotechnology company that develops regenerative medicine products and therapeutics targeting lymphatic regeneration for the treatment of infertility and other fibrotic conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LYMPHOGENiX Limited Comparables
Compare LYMPHOGENiX Limited with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Freya Biosciences | 63% | |
| Ferring Pharmaceuticals | 60% | |
| Tempest Therapeutics | 58% |
LYMPHOGENiX Limited Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Jul 8, 2025 |
Key People
Founding team and executive leadership
LYMPHOGENiX Limited Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Keio Innovation Initiative | Pre Seed |
| GLOCALINK Inc. | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 8, 2025
$340K raised from GLOCALINK Inc. and Keio Innovation Initiative.
LYMPHOGENiX Limited Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about LYMPHOGENiX Limited's valuation, stock price, and market status.
Is LYMPHOGENiX Limited a public or private company?
LYMPHOGENiX Limited is a private company.
What is the current stock price of LYMPHOGENiX Limited?
LYMPHOGENiX Limited is a private company with no public stock price. Caplight tracks LYMPHOGENiX Limited's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is LYMPHOGENiX Limited worth (valuation)?
Valuation information for LYMPHOGENiX Limited is not publicly available.
Can I buy LYMPHOGENiX Limited stock?
LYMPHOGENiX Limited shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was LYMPHOGENiX Limited's last funding round?
LYMPHOGENiX Limited's most recent funding round was Pre Seed on July 8, 2025.
Who are the main investors in LYMPHOGENiX Limited?
Key investors in LYMPHOGENiX Limited include Keio Innovation Initiative, GLOCALINK Inc..
Will LYMPHOGENiX Limited IPO soon?
No public IPO plans have been announced for LYMPHOGENiX Limited.
How can I track LYMPHOGENiX Limited secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor LYMPHOGENiX Limited's secondary market activity and sign up for updates.